The Patent Finder

Jiangsu Simcere Pharmaceutical Co., Ltd.

Also on record
Records under this name other than the patents Jiangsu Simcere Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Showing 1 to 2 of 2 · Back to Jiangsu Simcere Pharmaceutical Co., Ltd.

PatentTitleStatus Expires Confidence
US 12,297,284Anti-TNFR2 antibody and use thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,802,824Modified Recombinant Human Endostatin and Uses Thereof
Lapsed on the fee record
Ended Aug 12, 2026 · High confidence
Lapsed on the fee recordEnded Aug 12, 2026High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited